My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 230

    1.

    Increased clearance of propranolol in thyrotoxicosis.

    Feely J, Stevenson IH, Crooks J.

    Ann Intern Med. 1981 Apr;94(4 pt 1):472-4.PMID: 7212504 [PubMed - indexed for MEDLINE]Related articles

    2.

    Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.

    Wells PG, Feely J, Wilkinson GR, Wood AJ.

    Clin Pharmacol Ther. 1983 May;33(5):603-8.PMID: 6839632 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pharmacokinetics of propranolol and sotalol in hyperthyroidism.

    Aro A, Anttila M, Korhonen T, Sundquist H.

    Eur J Clin Pharmacol. 1982;21(5):373-7.PMID: 7075642 [PubMed - indexed for MEDLINE]Related articles

    4.

    Propranolol dosage in thyrotoxicosis.

    Feely J, Forrest A, Gunn A, Hamilton W, Stevenson I, Crooks J.

    J Clin Endocrinol Metab. 1980 Sep;51(3):658-61.PMID: 7410541 [PubMed - indexed for MEDLINE]Related articles

    5.

    A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.

    Wilkinson R, Burr WA.

    Am Heart J. 1984 Oct;108(4 Pt 2):1160-7.PMID: 6148879 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.

    Jacobs G, Whittem T, Sams R, Calvert C, Ferguson D.

    Am J Vet Res. 1997 Apr;58(4):398-403.PMID: 9099387 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of thyroid dysfunction on propranolol kinetics.

    Riddell JG, Neill JD, Kelly JG, McDevitt DG.

    Clin Pharmacol Ther. 1980 Nov;28(5):565-74.PMID: 7438675 [PubMed - indexed for MEDLINE]Related articles

    8.

    Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

    Hallengren B, Nilsson OR, Karlberg BE, Melander A, Tegler L, Wåhlin-Boll E.

    Eur J Clin Pharmacol. 1982;21(5):379-84.PMID: 7075643 [PubMed - indexed for MEDLINE]Related articles

    9.

    Steady state pharmacokinetics of propranolol in Saudi Arabian patients and comparison with data for different populations.

    el-Yazigi A, el-Baage T, al-Humaidan A, Yusuf A.

    J Clin Pharmacol. 1990 Feb;30(2):144-50.PMID: 2312765 [PubMed - indexed for MEDLINE]Related articles

    10.

    The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration.

    Feely J, Crooks J, Stevenson IH.

    Br J Clin Pharmacol. 1981 Jul;12(1):73-8.PMID: 6264937 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Propranolol dynamics in thyrotoxicosis.

    Feely J, Stevenson IH, Crooks J.

    Clin Pharmacol Ther. 1980 Jul;28(1):40-4.PMID: 7389252 [PubMed - indexed for MEDLINE]Related articles

    12.

    Propranolol as primary therapy for thyrotoxicosis.

    Mazzaferri EL, Reynolds JC, Young RL, Thomas CN, Parisi AF.

    Arch Intern Med. 1976 Jan;136(1):50-6.PMID: 1108824 [PubMed - indexed for MEDLINE]Related articles

    13.

    Kinetics and cardiac effects of propranolol in humans.

    Ochs HR, Grube E, Greenblatt DJ, Knüchel M, Bodem G.

    Klin Wochenschr. 1982 May 17;60(10):521-5.PMID: 7098380 [PubMed - indexed for MEDLINE]Related articles

    14.

    No stereoselective first-pass hepatic extraction of propranolol.

    Jackman GP, McLean AJ, Jennings GL, Bobik A.

    Clin Pharmacol Ther. 1981 Sep;30(3):291-6.PMID: 7273593 [PubMed - indexed for MEDLINE]Related articles

    15.

    Propranolol and the hypercalcaemia of thyrotoxicosis.

    Feely J.

    Acta Endocrinol (Copenh). 1981 Dec;98(4):528-32.PMID: 7304079 [PubMed - indexed for MEDLINE]Related articles

    16.

    No enhanced elimination of propranolol in patients with hyperthyroidism.

    Ishizaki T, Masuno M, Tawara K.

    Res Commun Chem Pathol Pharmacol. 1980 Sep;29(3):473-85.PMID: 7423023 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacokinetics in drug therapy. I: Propranolol hydrochloride as adjunct therapy in the treatment of thyrotoxicosis.

    Robayo JR.

    Am J Hosp Pharm. 1976 Feb;33(2):169-73.PMID: 56890 [PubMed - indexed for MEDLINE]Related articles

    18.

    Paracetamol pharmacokinetics in thyroid disease.

    Forfar JC, Pottage A, Toft AD, Irvine WJ, Clements JA, Prescott LF.

    Eur J Clin Pharmacol. 1980 Oct;18(3):269-73.PMID: 7439247 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nonlinear pharmacokinetics of unbound propranolol after oral administration.

    Straka RJ, Lalonde RL, Pieper JA, Bottorff MB, Mirvis DM.

    J Pharm Sci. 1987 Jul;76(7):521-4.PMID: 3668812 [PubMed - indexed for MEDLINE]Related articles

    20.

    Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.

    Bai SA, Walle UK, Walle T.

    J Pharmacokinet Biopharm. 1985 Jun;13(3):229-41.PMID: 4087163 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity